Medicare Bars New ‘Seamless Conversion’ Efforts For Some Seniors
(By Susan Jaffe for Kaiser Health News) The federal government is temporarily blocking more health insurance companies from automatically moving
Read More
Part D/Prescription Drugs
FTC seeks review of a court ruling on generic drug competition
(By Ed Silverman for STAT) The US Federal Trade Commission has once again waded into a closely watched legal battle
Read MoreAn EpiPen alternative is about to return to your local pharmacy
(By Ed Silverman for STAT) The controversial EpiPen device is about to get still more competition. A company that now
Read MoreHow To Enroll In Medicare And Avoid Costly Mistakes
(By Judith Graham for Kaiser Health News) Your 65th birthday is coming up. Soon, you think, the government will send
Read MoreSimplified Study Aims To Quickly Test A Long-Shot ALS Treatment
(By Richard Harris for NPR) Researchers have launched an innovative medical experiment that’s designed to provide quick answers while meeting
Read MoreGlaxoSmithKline Files for Regulatory Approval for Shingrix
GlaxoSmithKline has filed for U.S. regulatory approval for their shingles vaccine Shingrix which has shown greater protection among older recipients
Read MoreFifty Countries without Adequate Supplies of the Polio Vaccine
With polio on the brink of global eradication, Jon Abramson of World Health Organization stated there are only two manufacturers
Read MoreSanders seeks Ariad data on cancer drug price hikes
(By Ed Silverman for STAT) Call it Bernie Sanders vs. Ariad Pharmaceuticals, Act Two. The Vermont senator and erstwhile presidential
Read MoreGilead asks FDA to expand exclusivity for a key HIV drug
(By Ed Silverman for STAT) n the latest development in a heated battle between Gilead Sciences and the US Food
Read MoreFDA official warns other drug makers not to copy Sarepta
(By Ed Silverman for STAT) Any company that plans to mimic the approach taken by Sarepta Therapeutics to win regulatory
Read More